• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT ANTI-HBS REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT ANTI-HBS REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 07C18-42
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/18/2022
Event Type  malfunction  
Event Description
The customer observed false reactive architect anti-hbs result for one patient that did not match with the patient¿s historical result.The sample was repeated, and the results were nonreactive.The following data was provided: reference range: > / = 10.0 miu/ml is reactive.On (b)(6) 2022 sid (b)(6) initial result = 29.52 miu/ml, repeat results = 0.04 miu/ml, 0.12 miu/ml historical anti-hbs result: 0 miu/ml ((b)(6)2021) the customer released 0 miu/ml as a valid result.No impact to patient management was reported.
 
Manufacturer Narrative
Patient identifier: complete sid is (b)(6).All available patient information was included.Additional patient details are not available.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
This report is being filed on an international product, architect anti-hbs, list number 07c18, that has a similar product distributed in the us, architect ausab, list number 01l82.The complaint investigation for false reactive architect anti-hbs result included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, and labeling review.In-house testing of retained reagent kit was also completed.Return testing was not performed as returns were not available.The customer observed a discoloration build up on the inner wall of the sample wash cup which could have contaminated the initial test.Data and information provided by the customer were reviewed and support the complaint issue.The ticket search determined normal complaint activity for the likely cause lot.A review of tracking and trending did not identify any related trends for the product for the complaint issue.Performance testing was completed using an in-house retained reagent kit of lot 35580fn00.All specifications were met indicating the lot is performing acceptably.The device history record was reviewed and did not identify any non-conformances or deviations associated with the complaint issue.Labeling was reviewed and sufficiently addresses the customer¿s issue.Per product labelling, if the anti-hbs results are inconsistent with clinical evidence, additional testing is suggested to confirm the result.For diagnostic purposes, results should be used in conjunction with patient history and other hepatitis markers for diagnosis of acute, chronic, or recovered infection.The overall specificity for the architect anti-hbs assay (determined by considering result values of = 10.00 miu/ml as reactive) was estimated to be 99.22% at the lower 95% confidence level, therefore false reactive results may at times occur.False positive results may arise as a result of sample or reagent integrity issues at time of testing and details regarding sample and reagent handling are provided within the product package insert.Based on the investigation, no systemic issue or product deficiency for architect anti-hbs reagent lot 35580fn00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HBS REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key15390936
MDR Text Key303559454
Report Number3008344661-2022-00105
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Reporter Country CodeID
PMA/PMN Number
P050051
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/09/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/13/2023
Device Catalogue Number07C18-42
Device Lot Number35580FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/28/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6)
-
-